Skip to main content
Top
Published in: Endocrine Pathology 1/2007

01-05-2007

Comparative Immunohistochemical Assessment of Craniopharyngioma and Related Lesions

Authors: Brian H. Le, Javad Towfighi, Silloo B. Kapadia, M. Beatriz S. Lopes

Published in: Endocrine Pathology | Issue 1/2007

Login to get access

Abstract

Craniopharyngiomas (CP), Rathke’s cleft cysts (RCC), and sellar xanthogranulomas (XG) are closely related lesions. As expression of cytokeratins 8 (CK8) and 20 (CK20) was reported in RCC but not in CP, the present study investigates the reproducibility of immunohistochemical distinction between CP and RCC, attempting to identify the relationship of XG to these lesions. A comparative study of 55 patient specimens (25 CP, 28 RCC, and 2 XG) was analyzed for the histological features of xanthomatous changes and squamous metaplasia, and expression of CK8 and CK20. In the 25 CP cases, xanthomatous changes were seen in 5 (20%), with CK8 reactivity demonstrated in all 25 cases. A prominent xanthomatous component was identified in 13 of 28 RCC (46%), and squamous metaplasia was seen in 11 (39%), 9 of which also contained xanthomatous features. CK8 reactivity was demonstrated in all 28 RCC cases, whereas CK20 was seen only in 9 cases (32%). Of the two cases diagnosed as XG, none contained epithelium, and immunohistochemistry for cytokeratins was not observed. Overall, differential expression of cytokeratins cannot reliably distinguish CP from RCC. Furthermore, expression of CK20 in RCC is generally seen within a background of prominent squamous metaplasia and reactive xanthomatous changes.
Literature
1.
go back to reference Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–51, 1998.CrossRefPubMed Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–51, 1998.CrossRefPubMed
2.
go back to reference Janzer RC, Burger PC, Giangaspero F, Paulus W. Craniopharyngioma. In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press; p. 244–6, 2000. Janzer RC, Burger PC, Giangaspero F, Paulus W. Craniopharyngioma. In: Kleihues P, Cavenee WK, editors. Pathology and genetics of tumours of the nervous system. Lyon, France: IARC Press; p. 244–6, 2000.
3.
go back to reference Smith AR, Elsheikh TM, Silverman JF. Intraoperative cytologic diagnosis of suprasellar and sellar cystic lesions. Diagn Cytopathol 20:137–47, 1999.CrossRef Smith AR, Elsheikh TM, Silverman JF. Intraoperative cytologic diagnosis of suprasellar and sellar cystic lesions. Diagn Cytopathol 20:137–47, 1999.CrossRef
4.
go back to reference Szeifert GT, Sipos L, Horvath M, Sarker MH, Major O, Salomvary B, Czirjak S, Balint K, Slowik F, Kolonics L. Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir 124:139–43, 1993.CrossRef Szeifert GT, Sipos L, Horvath M, Sarker MH, Major O, Salomvary B, Czirjak S, Balint K, Slowik F, Kolonics L. Pathological characteristics of surgically removed craniopharyngiomas: analysis of 131 cases. Acta Neurochir 124:139–43, 1993.CrossRef
5.
go back to reference Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg 56:501–10, 1983. Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal. Oral Surg 56:501–10, 1983.
6.
go back to reference Kasai H, Hirano A, Llena JF, Kawamoto K. A histopathological study of craniopharyngioma with special reference to its stroma and surrounding tissue. Brain Tumor Pathol 14:41–5, 1997.CrossRefPubMed Kasai H, Hirano A, Llena JF, Kawamoto K. A histopathological study of craniopharyngioma with special reference to its stroma and surrounding tissue. Brain Tumor Pathol 14:41–5, 1997.CrossRefPubMed
7.
go back to reference Badger KV, Gardner DG. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med 26:349–55, 1997.CrossRefPubMed Badger KV, Gardner DG. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. J Oral Pathol Med 26:349–55, 1997.CrossRefPubMed
8.
go back to reference Duff JM, Meyer FB, Ilstrup DM, Laws ER, Schleck CD, Scheithauer BW. Long-term outcomes for surgically resected craniopharyngiomas. Neruosurgery 46:291–305, 2000.CrossRef Duff JM, Meyer FB, Ilstrup DM, Laws ER, Schleck CD, Scheithauer BW. Long-term outcomes for surgically resected craniopharyngiomas. Neruosurgery 46:291–305, 2000.CrossRef
9.
go back to reference Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw EG, Miller GM, Burger PC. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–14, 1995.CrossRefPubMed Crotty TB, Scheithauer BW, Young WF, Davis DH, Shaw EG, Miller GM, Burger PC. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–14, 1995.CrossRefPubMed
10.
go back to reference Fahlbusch R, Hnegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–50, 1999.CrossRefPubMed Fahlbusch R, Hnegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237–50, 1999.CrossRefPubMed
11.
go back to reference Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg 74:535–44, 1991.CrossRefPubMed Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg 74:535–44, 1991.CrossRefPubMed
12.
go back to reference Wolfsohn AL, Lach B, Benoit BG. Suprasellar xanthomatous Rathke’s cleft cyst. Surg Neurol 38:106–9, 1992.CrossRefPubMed Wolfsohn AL, Lach B, Benoit BG. Suprasellar xanthomatous Rathke’s cleft cyst. Surg Neurol 38:106–9, 1992.CrossRefPubMed
13.
go back to reference Uematsu Y, Rojas-Corona RR, Llena JF, Hirano A. Epithelial cysts in the central nervous system, characteristic expression of cytokeratins in an immunohistochemical study. Acta Neurochir 107:93–101, 1990.CrossRef Uematsu Y, Rojas-Corona RR, Llena JF, Hirano A. Epithelial cysts in the central nervous system, characteristic expression of cytokeratins in an immunohistochemical study. Acta Neurochir 107:93–101, 1990.CrossRef
14.
go back to reference Kim JE, Jung HW. Diagnosis and treatment of symptomatic Rathke cleft cyst. Neurosurg Q 13:64–76, 2003.CrossRef Kim JE, Jung HW. Diagnosis and treatment of symptomatic Rathke cleft cyst. Neurosurg Q 13:64–76, 2003.CrossRef
15.
go back to reference Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 84:3972–82, 1999.CrossRefPubMed Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 84:3972–82, 1999.CrossRefPubMed
16.
go back to reference Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg 101:577–84, 2004.CrossRefPubMed Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg 101:577–84, 2004.CrossRefPubMed
17.
go back to reference Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH. Surgical outcomes in 118 patients with Rathke cleft cyst. J Neurosurg 102:189–93, 2005.PubMed Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH. Surgical outcomes in 118 patients with Rathke cleft cyst. J Neurosurg 102:189–93, 2005.PubMed
18.
go back to reference Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol (Berl) 97:377–82, 1999.CrossRef Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol (Berl) 97:377–82, 1999.CrossRef
19.
go back to reference Xin W, Rubin MA, McKeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 126:1174–8, 2002.PubMed Xin W, Rubin MA, McKeever PE. Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from Rathke cleft cyst. Arch Pathol Lab Med 126:1174–8, 2002.PubMed
20.
go back to reference Kurosaki M, Saeger W, Ludecke DK. Immunohistochemical localisation of cytokeratins in craniopharyngioma. Acta Neurochir 143:147–51, 2001.CrossRef Kurosaki M, Saeger W, Ludecke DK. Immunohistochemical localisation of cytokeratins in craniopharyngioma. Acta Neurochir 143:147–51, 2001.CrossRef
21.
go back to reference Uematsu Y, Komai N, Hirano A, Shimizu M, Tanaka Y, Naka D, Yukawa S, Itakura T, Hayashi S. Cytokeratin immunohistochemical study of epithelial cysts in the central nervous system: with special reference to origins of colloid cyst of the third ventricle and Rathke’s cleft cyst in the sella. Noshuyo Byori 10:43–52, 1993.PubMed Uematsu Y, Komai N, Hirano A, Shimizu M, Tanaka Y, Naka D, Yukawa S, Itakura T, Hayashi S. Cytokeratin immunohistochemical study of epithelial cysts in the central nervous system: with special reference to origins of colloid cyst of the third ventricle and Rathke’s cleft cyst in the sella. Noshuyo Byori 10:43–52, 1993.PubMed
22.
go back to reference Tateyama H, Tad T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract 197:735–52, 2001.CrossRefPubMed Tateyama H, Tad T, Okabe M, Takahashi E, Eimoto T. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas. Pathol Res Pract 197:735–52, 2001.CrossRefPubMed
23.
Metadata
Title
Comparative Immunohistochemical Assessment of Craniopharyngioma and Related Lesions
Authors
Brian H. Le
Javad Towfighi
Silloo B. Kapadia
M. Beatriz S. Lopes
Publication date
01-05-2007
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 1/2007
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-007-0011-y

Other articles of this Issue 1/2007

Endocrine Pathology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine